Pancreatic Cancer Research

ResearcherMassachusetts Institute of TechnologyActive in the last 2 years

Zackery A. Ely

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9694-0341; OpenAlex author ID A5091523559; NIH RePORTER profile ID 15736427. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
1
Labs led
0
Collaborators
12
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper, 1 grant · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Pancreatic cancer-restricted cryptic antigens are targets for T cell recognition. Co-author DOI 10.1126/science.adk3487↗
  2. Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment. Co-author DOI 10.1038/s41588-022-01134-8↗
  3. The CD155/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer. Co-author DOI 10.1016/j.ccell.2021.07.007↗

Grants 1

  1. Comprehensive modeling of tumor suppressor gene-derived neoantigens in pancreatic cancer F31CA268835↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. William A. Freed-Pastor · 2 shared papers, 2021–2025 · strength 0.27
  2. Tyler Jacks · 2 shared papers, 2021–2025 · strength 0.27
  3. Steven A. Carr · 1 shared paper, 2025 · strength 0.17
  4. Srivatsan Raghavan · 1 shared paper, 2025 · strength 0.17
  5. Philip D. Greenberg · 1 shared paper, 2025 · strength 0.17
  6. Andrew J. Aguirre · 1 shared paper, 2025 · strength 0.17
  7. Brian Matthew Wolpin · 1 shared paper, 2025 · strength 0.17
  8. James M. Cleary · 1 shared paper, 2025 · strength 0.17
  9. William L. Hwang · 1 shared paper, 2021 · strength 0.10
  10. Peter M.K. Westcott · 1 shared paper, 2021 · strength 0.10
  11. Aviv Regev · 1 shared paper, 2021 · strength 0.10
  12. Vikram Deshpande · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.